Allergy & Immunology Doctors in Newark, DE Accepting Medicare

5 Allergy & Immunology doctors found. Showing 1 - 5

Dr. William John Geimeier, M.D. Allergy & Immunology - Allergy Medicare: Not Enrolled in Medicare Practice Location: 179 W Chestnut Hill Rd, Suite 1, Newark, DE 19713 Phone: 302-453-1343    Fax: 302-453-1654

Junfang Jiao, Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 700 Prides Xing Ste 200, Newark, DE 19713 Phone: 302-998-0300    Fax: 302-543-8456

Dr. Quan Chung Nguyen, M.D. Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 700 Prides Xing Ste 200, Newark, DE 19713 Phone: 302-998-0300    Fax: 302-543-8456

Sokun Ky Bhatti, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 700 Prides Xing Ste 200, Newark, DE 19713 Phone: 302-998-0300

Thomas Graves, Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 700 Prides Xing Ste 200, Newark, DE 19713 Phone: 302-998-0300

News Archive

Study shows how fingerprint-based drug screening works on the living and deceased

New research published in the Journal of Analytical Toxicology shows how fingerprint-based drug screening can not only screen for the presence, or absence, of four classes of drugs of abuse, but that the technology also works when used by UK coroners to detect drugs in the sweat of fingerprint samples gathered from deceased individuals.

Mesoblast reports positive Revascor Phase 2 heart failure trial results

Regenerative medicine company Mesoblast Limited today announced positive Phase 2 heart failure trial results of its allogeneic, or off-the-shelf, adult stem cell product Revascor after all patients had completed a minimum follow-up of 12 months, and a mean follow-up of 22 months.

Synthetic microRNA can serve as a novel therapeutic agent for treating human cancer

Oncotarget published "Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology" which reported that the authors comprehensively investigated miRNA-193a-3p's mode of action in a panel of human cancer cell lines, with a variety of genetic backgrounds, using 1B3, a synthetic microRNA mimic

PHLI announces marketing campaign for FORZE GPS bars and drinks

PacificHealth Laboratories, Inc. (OTCBB: PHLI), a leading sports nutrition company, is pleased to announce three marketing initiatives for FORZE GPS™ bars and drinks, the first scientifically proven appetite control tools created specifically for athletes.

Read more Medical News

› Verified 3 days ago